- Report
- March 2025
- 182 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- May 2024
- 200 Pages
Global
From €3940EUR$4,150USD£3,323GBP
- Report
- February 2024
- 113 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- April 2023
- 115 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- February 2024
- 111 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- July 2023
- 104 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- April 2024
- 132 Pages
Global
From €902EUR$950USD£761GBP
- Report
- January 2023
- 235 Pages
Global
From €3389EUR$3,570USD£2,859GBP
- Book
- September 2020
North America

Analgesia is a form of palliative care that focuses on relieving pain and other symptoms associated with serious illnesses. It is an important part of palliative care, as it helps to improve the quality of life for those living with a terminal illness. Analgesia can be administered through a variety of methods, including oral medications, injections, topical creams, and nerve blocks. The goal of analgesia is to reduce pain and improve the patient's overall quality of life.
The analgesia market is a rapidly growing sector of the palliative care industry. It is driven by the increasing prevalence of chronic pain and the need for effective pain management. The market is expected to continue to grow as more people are diagnosed with chronic pain and the need for effective pain management increases.
Companies in the analgesia market include AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more